Skip NavigationSkip to Content
NCI HeaderNational Cancer InstituteU.S. National Institutes of
CCR - For Our Staff| Home |

Translational Research in Clinical Oncology (TRACO)


Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The Center for Cancer Research (CCR) of the NCI is one of the largest centers for cancer research in the world, with approximately 250 principal investigators, and has played a major role in development and implementation of many new technologies, such as nanotechnology, genomics and proteomics.

The Translational Research in Clinical Oncology (TRACO) course will be held on Monday afternoons from September to December at the Bethesda campus, Bldg. 50 ground floor auditorium. TRACO is designed to provide an overview of general principles of cancer biology and treatment, epidemiology, mechanisms of resistance, metastasis, use of preclinical models, and identification of novel molecular targets. Participants will have an unprecedented opportunity to learn new information, glimpse into future developments of translational research in clinical oncology, meet leaders in cancer research, and interview cancer survivors. The participation of NIH postdoctoral and clinical fellows is encouraged.


Related Training Opportunities:

This course is part of an ongoing training curriculum for NCI clinical and postdoctoral fellows. TRACO complements other topics in human diseases and therapies covered in Demystifying Medicine, which is hosted by Dr. Irwin M. Arias. Other classes offered periodically by the CCR Office of Training and Education include: Redox Biology, Statistical Analysis of Research Data , Cancer Biotechnology, Teaching In Medical Education, and Scientific Management Training . For additional postdoctoral training opportunities at NIH visit

Location and Time:
Two 1-hour sessions will usually occur on Mondays, 4:00 to 6:00 pm in the Bldg. 50 ground floor auditorium (Rooms 1227/1233) with videoconferencing to NCI-Frederick (Bldg. 549, Rm. A). In addition, lectures will be archived at Each session will have two 50-minute lectures in basic and clinical sciences with ample time for discussion and analysis. A handout for each lecture will be distributed on site.

Participants who register for this course may receive a certificate of completion after attending the lectures and completing an online examination.

Additional Activities:
Course registrants can also attend NCI tumor boards, CCR Grand Rounds, and/or visit technical facilities. Please contact Dr. Moody to make appropriate reservations.



Irwin Arias, MD C. Annunziata, MD O. Olaku, MD
Terry Moody, PhD K. Camphausen, MD Y. Pommier, MD
Lyuba Varticovski, MD N. Caplen, PhD D. Salomon, PhD
Jonathan Wiest, PhD N. Caporaso, MD J. Schiller, MD
Farah Zia, MD P. Choyke, MD A. Simeonow, PhD
  M. Dobrovolskaia, MD J. Smith, MD
  J. Gulley, MD E. Szabo, MD
  C. Harris, MD M. Verma, MD
  P. Hussain, PhD W. Wilson, MD
  S. Jakowlew, PhD M. Young, PhD
  J. Khan, MD F. Zia, MD
  F. Maldarelli, MD E. Zudaire, PhD
  T. Moody, PhD  



Lecture 1 (4:00 p.m.)

Lecture 2 (5:00 p.m.)

Sept. 9 Introduction Translational Research
Sept. 16 Ovarian Cancer Prostate Cancer
Sept. 23 Retroviruses Topoisomerase Drugs
Sept. 30 Small Cell Lung Cancer (SCLC) TGF-beta
Oct. 7 Breast Cancer Imaging of Cancer
Oct. 21 Tumor Imaging Small Molecules
Oct. 28 Cancer Stem Cells Epidemiology
Nov. 4 HPV Vaccines Epigenetics
Nov. 11 RNAi Angiogenesis
Nov. 18 Lymphomas Genomics
Nov. 25 Micro RNA and Inflammation Non-SCLC
Dec. 2 Colon Cancer Case Reports
Dec. 9 Nanotechnology Pancreatic Cancer
Home | Contact Us | Policies | Accessibility | Viewing Files | Search | CCR - For Our Staff

A service of the National Cancer Institute

National Cancer InstituteNational Institutes of HealthHealth and Human ServicesUSA Gov - Official Web Portal